The temporal acquisition of in vitro phenotypes associated with neoplasia was examined after exposure of Syrian hamster embryo cells to a chemical carcinogen. Quantitative assays measuring morphological changes, enhanced fibrinolytic activity, and anchorage independent growth were used to detect the development of transformed cells within a population of normal hamster embryo cells. Morphological transformation and enhanced fibrinolytic activity were early changes observed after treatment with benzo[aJpyrene, whereas the ability to grow in semisolid agar was delayed 32-75 population doublings after carcinoen exposure. This delay was not due to selection of a small number of cells that were present early after treatment but at a level below detection, because a large percentage of the cells isolated at early passage (103-fold above the level of detection) developed the potential for anchorage independent growth at later passages. This development of the anchorage independent growth phenotype was induced by the carcinogen treatment, because spontaneous transformation was rare. These observations suggest that multiple cellular changes are required for the acquisition of the capacity for anchorage independent growth andthat neoplastic transformation in vitro is a progressive process through qualitatively different stages. Thus, an analogy can be drawn to the progressive nature of in vivo carcinogenesis. These results strongly justify the study of oncogenesis in cell culture as a model for neoplastic transformation in vivo. The concept of progression as defined by Foulds is one of stepwise neoplastic development through qualitatively different stages (1, 2). The progressive nature of a number of in vivo malignancies has been documented (1, 2). Since neoplastic transformation in vitro is assumed to reflect neoplastic development in vivo, the demonstration of progression during in vitro transformation is important in illustrating a parallel between in vitro and in vivo carcinogenesis.
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Syrian hamster embryo cells in culture provide a useful model system for studying neoplastic transformation in vitro because they are stably diploid, have a low incidence of spontaneous transformation, and can be induced by chemical carcinogens to undergo neoplastic transformation (3) (4) (5) (6) . In addition to acquiring malignant potential transformed hamster cells exhibit several other in vitro phenotypic characteristics often associated with neoplasia. These altered phenotypes can serve as useful markers in studying cell transformations. The detection of the phenotypes, however, requires quantitative assays with sensitivities sufficient to detect a few transformed cells within a population of normal cells.
Morphological transformation (4) , enhanced fibrinolytic activity (7) (8) (9) , and growth in soft agar (10) (11) (12) were the cellular changes chosen for study. Syrian hamster embryo cells were treated with benzo[a]pyrene (BzP) and the temporal acquisition of each of these altered characteristics was found to be independent (13) . Morphological alterations were the earliest changes, followed by enhanced fibrinolytic activity; both of these phenotypes were expressed within 2 weeks after treatment, but were not necessarily correlated (13) . Cells capable of growth in soft agar were not detected until a much later time. Evidence is presented in this paper that this delay in the expression of anchorage-independent growth indicates that neoplastic transformation in vitro is progressive in nature, involving multiple developmental stages.
MATERIALS AND METHODS Cells. Syrian hamster embryo cell cultures were established from 13-day-gestation fetuses from inbred Syrian hamsters, as described (13, 14) .
Assays for Transformed Phenotypes. Morphological transformation (as illustrated in Fig. 1 ) was scored as the number of transformed colonies per total surviving colonies by using described criteria (4, 5, 15) . Enhanced fibrinolytic activity of individual transformed colonies was measured quantitatively by the appearance of clear zones of lysis in a fibrin/agarose overlay above the colonies (13) .
Colony formation in agar was measured as described (11) (12) (13) (Table 1) .
For tumorigenicity studies, 2 X 106 cells were injected subcutaneously into nonimmunosuppressed neonatal Syrian hamsters (Lakeview). Animals were observed for a period up to 1 yr.
Transformation Studies. Tertiary passage hamster cells were plated at 5 X I05 cells per 75 cm2 flask, allowed to attach overnight at 370, and then treated with BzP for 24 hr (13) . Control cultures were treated with solvent only (0.1% dimethylsulfoxide). After treatment, all cultures were washed and incubated until nearly confluent. The cultures were then trypsinized and subcultures of 1-5 X 105 cells were initiated. Cells from the cultures were also plated at low density for cloning (5-10 X 103 cells per 100 mm petri plate) for 7-8 days of growth to examine resulting colonies for morphological transformation and fibrinolytic activity. At each passage, 200-600 colonies from each culture were scored for morphological transformation, 400-1000 colonies were examined for fibrinolytic activity, and 106 cells were tested for growth in semisolid agar. The passages are numbered from the first passage after treatment, called post-treatment passage number one (PTP-1). This process was repeated at each PTP. The cells were passaged at confluency, every 6-9 days. Since the first subcul- (ii) addition of this value to the population doubling level achieved by the original treated culture, prior to plating for colony isolation. Table 3 .
Both morphological transformation and enhanced fibrinolytic activity were observed within 2 weeks after carcinogen exposure; however, morphological transformation was observed before enhanced fibrinolytic activity (13) . Anchorage independent growth was a later phenotypic change, not detected until [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] At the time the initial isolations were performed, no colonies were detected in soft agar when 106 cells from the mass culture were tested. In fact, the mass culture was tested at every passage after treatment, and no colonies were detected in agar until PTP-9 (46 population doublings after treatment, Table 3 ). These results clearly indicate that in early passages, the fraction of the population expressing the anchorage-independent phenotype had to have been exceedingly small. Therefore, if the transformation process had been completed at early PTPs and fully transformed cells were present, the probability of randomly isolating from the fibrin/agarose overlay a colony capable of growth in agar would have to be very low.
Nevertheless, a fraction of the population may have existed that had the potential for anchorage-independent growth, though the expression of this phenotypic characteristic was absent in early passages. For this reason, we searched for cells in the population at PTP-3 (13 population doublings after treatment) that would possess such potential, because we assumed that this period allowed sufficient time to establish any carcinogen-induced changes. As shown in Table 4 , we were able, with a high frequency, to isolate colonies with the potential of expressing the anchorage-independent phenotype after additional culturing in vitro.
At PTP-3, nine colonies which possessed enhanced fibrinolytic activity were isolated from this culture. From these nine Observed soft agar clones at PTP-3/cells assayedl 0/106 * Cells were exposed to BzP at 10 ,ug/ml for 24 hr, grown in mass culture, and assayed at the third passage after treatment for colonies that possessed enhanced fibrinolytic activity and growth ability in soft agar as described in Table 3 . t The colonies possessing enhanced fibrinolytic activity were isolated and grown until a total of 55 population doublings after treatment were attained, and the colonies were then assayed for growth in soft agar. t Calculated from the percentage of fibrinolytic positive colonies in the whole culture (17.5%) and the fraction of these colonies that developed the ability to grow in agar (5/9) or (17.5% X 5/9). § Since 9.7% of all the cells in culture at PTP-3 had the potential to develop into soft agar-positive clones at later passages, this culture should have this number of cells at PTP-3 for these cells to express the capacity for growth in soft agar at this time after treatment. Five clones in soft agar were isolated and their plating efficiencies in agar were determined and found to be 10 I 5%. The number of cells theoretically soft-agar positive therefore was corrected for this plating efficiency.
From Table 3. attempted isolations, seven lines were established and subcultured for greater than 20 passages. Eventually, all of these lines developed the ability to grow in agar. When these seven isolated colonies were tested for growth in soft agar at 55 population doublings after BzP treatment, five cultures possessed cells capable of forming colonies in soft agar at a frequency of 5-100 colonies per 106 cells. Cells from the other two cultures did not grow in agar until they reached a total of 75 population doublings. Additionally, fifteen colonies lacking detectable fibrinolytic activity were isolated; all of these isolates senesced in a similar manner as did the colonies from untreated cultures.
The theoretical fraction of the population at PTP-3 having the potential to grow in soft agar upon further growth can be calculated as follows (Table 4) : 17 .5% of the colonies from the treated mass culture possessed enhanced fibrinolytic activity at PTP-3. Of the nine isolates representative of such colonies, at least five developed the ability to grow in soft agar at 55 population doublings after treatment. Therefore, at least 9.7% of the total population theoretically had the potential to grow in agar after further growth in mass culture. Had these cells the full capability at PTP-3, then the theoretical number of colonies that would have been observed growing in soft agar at this early passage is 9.7 X 104 per 106 cells tested. Since, however, the observed number of colonies in agar depends also on the cloning efficiency in agar of these cells, a correction factor for this parameter was determined in the following manner. The colonies growing in agar, which were formed by the fibrinolytically active cells originally isolated at PTP-3 and grew in soft agar at 55 population doublings post-treatment, were isolated, grown to a sufficient number, and assayed for growth in agar. Five agar colonies were isolated and reassayed; the cloning efficiency of these cells was found to average 10 + 5%. After correcting for this 10% plating efficiency, we determined that the theoretical number of cells that could grow in soft agar at PTP-3 should be 9.7 x 103 per 106 cells, a frequency which is easily Proc. Natl. Acad. Sci. USA 75 (1978) detected by our methods (Table 1) . In fact, when 106 cells from the original cultures were assayed at PTP-3 for growth in-agar, no colony was observed (Table 3) . Therefore, we conclude that cells capable of anchorage-independent growth were not present at this stage in the transformation process, but, rather, developed only after additional growth in vitro.
DISCUSSION
In this communication, we have examined whether the cellular changes involved in neoplastic transformation in vitro can best be described either by a simple, one-step process, or by a multistep progressive process through qualitatively different stages. The pattern of temporal acquisition of phenotypic alterations of Syrian hamster embryo cells after treatment with BzP is shown in Table 3 . Morphological alterations were the earliest detectable changes, occurring within 1 week after carcinogen treatment (13) , while enhanced fibrinolytic activity required a slightly longer time period of 2-3 weeks before expression. The development of cells with the capability of anchorageindependent growth required a significantly longer (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) weeks) period of in vitro culturing. In fact, the latter phenotype developed in both mass culture (Table 3) Obviously, attempts to define and detect preneoplastic cells in the transformation process are of paramount importance. In this regard, understanding the relevance and interrelationships of phenotypic changes may be very useful. Our studies demonstrate an independent temporal acquisition of the phenotypic transformations of morphology, enhanced fibrinolytic activity, and the ability to grow in soft agar. Kakunaga and Kamahora (11) have reported morphologically normal cells that grow in soft agar. We have obtained similar cell lines and demonstrated that they possess enhanced fibrinolytic activity (unpublished data). These results suggest an independent development of each of these phenotypes associated with malignancy. This is consistent with the independent progression of different characters of a tumor in vivo.
Each of the in vitro correlates of neoplasia we have examined may be a spurious consequence of the transformation process and may have no necessary function in the maintenance of the malignant state. However, growth in soft agar appears to correlate well with tumorigenicity (11) , which suggests that the changes required for anchorage independence are important for tumor formation. Our results demonstrate that morphological transformation and enhanced fibrinolytic activity are not sufficient for tumorigenicity in Syrian hamster embryo cells, because late passage cells in untreated cultures possess enhanced fibrinolytic activity, yet they lack tumorigenicity and do not readily transform spontaneously into soft agar-positive cells. However, when fibrinolysis-positive colonies are isolated from carcinogen-treated cultures and continuously cultured, over 50% give rise to cells capable of growth in soft agar. This may suggest a role for fibrinolysis in neoplasia, although the possibility that enhanced fibrinolytic activity is merely a consequence of the in vitro transformation process cannot be excluded (13) .
In summary, we have presented evidence that neoplastic transformation in vitro is a progressive event analogous to in vivo carcinogenesis. This realization of the complex nature of neoplastic transformation in vitro should caution against the simplistic approach of applying "short-term" in vitro assays for quantitative risk assessment of suspected carcinogens.
